Guardant Health (GH) Sell-Off Makes Neogenomics (NEO) Deal Less Likely - Needham & Company
Go back to Guardant Health (GH) Sell-Off Makes Neogenomics (NEO) Deal Less Likely - Needham & CompanyTextainer Group Holdings limited (NASDAQ: GH) | Delayed: 17.45 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $17.45 | 52 Week High | $5.84 | |||
Open | $17.45 | 52 Week Low | $5.49 | |||
Day High | $17.45 | P/E | N/A | |||
Day Low | $17.45 | EPS | $0.00 | |||
Volume | 658 |
NEOGENOMICS (NASDAQ: NEO) | Delayed: 14.55 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $14.55 | 52 Week High | $9.54 | |||
Open | $14.55 | 52 Week Low | $5.49 | |||
Day High | $14.55 | P/E | 363.75 | |||
Day Low | $14.55 | EPS | $0.04 | |||
Volume | 234,033 |